DUO vs GRCE
Comparison between Fangdd Network Group Ltd - Class A (DUO, Company) and Acasti Pharma Inc (GRCE, Company).
DUO is from the Real Estate sector, while GRCE is from the Healthcare sector.
DUO vs GRCE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
DUO
$36M
Winner
GRCE
$36M
Max Drawdown
DUO
98.75%
Winner
GRCE
60.00%
Sharpe Ratio
DUO
-0.22
Winner
GRCE
0.02
5Y Beta
DUO
1.37
Winner
GRCE
0.89
Industry
DUO
Real Estate Services
GRCE
Biotechnology
P/E Ratio
DUO
-1.76
Winner
GRCE
-5.60
Forward P/E
DUO
N/A
GRCE
2.17
Debt to Equity
DUO
0.00%
GRCE
0.00%
Free Cash Flow Yield
DUO
-34.71%
Winner
GRCE
-28.33%
P/S Ratio
Winner
DUO
0.10
GRCE
197.75
P/B Ratio
Winner
DUO
0.42
GRCE
0.56
DUO vs GRCE - Historical Returns
Returns include dividend reinvestment.
1M
DUO
-33.14%
Winner
GRCE
-5.58%
3M
Winner
DUO
-27.07%
GRCE
-45.81%
6M
DUO
-54.74%
Winner
GRCE
-33.53%
1Y
DUO
-66.82%
Winner
GRCE
-24.66%
Max(CAGR)
DUO
-84.03%
Winner
GRCE
-17.23%
DUO vs GRCE - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | DUO | GRCE |
|---|---|---|
| 2026 | -43.79% | -39.89% |
| 2025 | -85.72% | -13.50% |
| 2024 | -52.53% | +23.84% |
DUO vs GRCE Drawdown Comparison
The maximum drawdown for DUO was -98.75%, occurring on Jun 8, 2026. This drawdown has not yet recovered.
The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.
The current DUO drawdown is -98.74%. The current GRCE drawdown is -57.12%.
| Rank | DUO | GRCE |
|---|---|---|
| #1 | -98.75% Oct 2, 2024 - Jun 8, 2026 | -60.00% Dec 6, 2024 - Mar 25, 2026 |
| #2 | N/A | -59.06% Apr 2, 2026 - Apr 28, 2026 |
| #3 | N/A | -18.06% Oct 23, 2024 - Dec 4, 2024 |
| #4 | N/A | -8.60% Mar 26, 2026 - Apr 1, 2026 |
| #5 | N/A | -5.57% Oct 10, 2024 - Oct 23, 2024 |
Correlation
Correlation between DUO and GRCE is 0.07 which considered as a very weak or no correlation - the stocks move independently of each other.
0.07
-101
Select Stocks to Compare
Popular: DUO vs SPYGRCE vs SPY
More Comparisons
Compare with similar stocks